• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管手术后可溶性尿激酶型纤溶酶原激活物受体水平与新发心房颤动的预测。

Preoperative Levels of the Soluble Urokinase-Type Plasminogen Activator Receptor as Predictor for New Episodes of Atrial Fibrillation After Vascular Surgery.

机构信息

Clinic of Cardiovascular and Transplant Surgery, 256420Clinical Center Niš, Niš, Serbia.

Department for Cardiac Surgery, Clinic for Anaesthesiology and Intensive Therapy, 256420Clinical Center Niš, Niš, Serbia.

出版信息

Vasc Endovascular Surg. 2021 Jul;55(5):461-466. doi: 10.1177/1538574421995321. Epub 2021 Feb 24.

DOI:10.1177/1538574421995321
PMID:33622185
Abstract

INTRODUCTION

The soluble urokinase-type plasminogen activator receptor (suPAR) in uPAR soluble form is produced when the uPAR is cleaved from the cell membrane during the inflammatory process. Postoperative atrial fibrillation (AF) is the most common perioperative cardiac arrhythmia. It is speculated that elevated suPAR has a role in the development of AF. The aim of our study was to investigate the predictive role of preoperative suPAR in the occurrence of AF during the first 6 months after major vascular surgery.

METHODS

We included 119 male and 63 female patients with an average age of 67.19 ± 6.02 years, without permanent/persistent AF. Basic predictive model (BASIC) included traditional risk factors for AF: age, gender, body mass index-BMI, smoking status, presence of arterial hypertension, diabetes mellitus and dyslipidemia.

RESULTS

Over the 6-month period, 19 (10.4%) patients had one new episode of atrial fibrillation and 2 patients (1.1%) had 2 episodes of paroxysmal atrial fibrillation. Paroxysms of AF were significantly more frequent in patients who had a resection of an abdominal aneurysm than in patients with other types of major vascular surgery. BASIC had good discriminatory ability in the prediction of AF paroxysms during the first 6 months after surgery (AUC = 0.715, 95%CI 0.590-0.840). Adding suPAR to the basic model significantly improved the discriminative ability of the predictive model for AF episodes (ΔAUC = 0.238, p < 0.001). The predictive performance of the model BASIC+CRP+suPAR, measured using AUC, NRI and IDI statistics, was very similar to the model BASIC+suPAR.

CONCLUSION

AF is a common complication in surgical patients with high mortality and morbidity. suPAR could improve the ability of traditional risk factors to predict its occurrence up to 6 months after major vascular surgery.

摘要

简介

尿激酶型纤溶酶原激活物受体(uPAR)可溶性形式的可溶性尿激酶型纤溶酶原激活物受体(suPAR)是在炎症过程中 uPAR 从细胞膜上裂解时产生的。术后心房颤动(AF)是最常见的围手术期心脏心律失常。据推测,升高的 suPAR 在 AF 的发展中起作用。我们的研究目的是探讨术前 suPAR 在大血管手术后 6 个月内发生 AF 的预测作用。

方法

我们纳入了 119 名男性和 63 名女性患者,平均年龄为 67.19 ± 6.02 岁,无永久性/持续性 AF。基本预测模型(BASIC)包括 AF 的传统危险因素:年龄、性别、体重指数-BMI、吸烟状况、动脉高血压、糖尿病和血脂异常的存在。

结果

在 6 个月期间,有 19 名(10.4%)患者出现了 1 次新的心房颤动发作,有 2 名患者(1.1%)出现了 2 次阵发性心房颤动发作。在接受腹主动脉瘤切除术的患者中,AF 阵发性发作的频率明显高于接受其他类型大血管手术的患者。BASIC 在预测术后 6 个月内 AF 阵发性发作方面具有良好的区分能力(AUC=0.715,95%CI 0.590-0.840)。将 suPAR 添加到基本模型中可显著提高预测模型对 AF 发作的区分能力(ΔAUC=0.238,p<0.001)。使用 AUC、NRI 和 IDI 统计数据衡量的模型 BASIC+CRP+suPAR 的预测性能与模型 BASIC+suPAR 非常相似。

结论

AF 是外科患者常见的并发症,具有较高的死亡率和发病率。suPAR 可以提高传统危险因素预测术后 6 个月内 AF 发生的能力。

相似文献

1
Preoperative Levels of the Soluble Urokinase-Type Plasminogen Activator Receptor as Predictor for New Episodes of Atrial Fibrillation After Vascular Surgery.血管手术后可溶性尿激酶型纤溶酶原激活物受体水平与新发心房颤动的预测。
Vasc Endovascular Surg. 2021 Jul;55(5):461-466. doi: 10.1177/1538574421995321. Epub 2021 Feb 24.
2
Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein.预测伴有 2 型糖尿病的非裔美国人的死亡率:可溶性尿激酶型纤溶酶原激活物受体、冠状动脉钙和高敏 C 反应蛋白。
J Am Heart Assoc. 2018 May 1;7(9):e008194. doi: 10.1161/JAHA.117.008194.
3
Increased plasma level of soluble urokinase plasminogen activator receptor is associated with incidence of heart failure but not atrial fibrillation.血浆可溶性尿激酶型纤溶酶原激活物受体水平升高与心力衰竭的发生有关,但与心房颤动无关。
Eur J Heart Fail. 2014 Apr;16(4):377-83. doi: 10.1002/ejhf.49.
4
Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments.可溶性尿激酶型纤溶酶原激活物受体(suPAR)作为现有术前风险评估的补充预测指标。
World J Surg. 2019 Mar;43(3):780-790. doi: 10.1007/s00268-018-4841-1.
5
Can soluble urokinase plasminogen receptor predict outcomes after cardiac surgery?可溶性尿激酶型纤溶酶原激活物受体能否预测心脏手术后的结局?
Interact Cardiovasc Thorac Surg. 2021 Jan 22;32(2):236-243. doi: 10.1093/icvts/ivaa239.
6
Soluble urokinase plasminogen activator receptor (suPAR) in children with obesity or type 1 diabetes as a marker of endothelial dysfunction: a cross-sectional study.可溶性尿激酶型纤溶酶原激活物受体(suPAR)在肥胖或 1 型糖尿病儿童中作为血管内皮功能障碍的标志物:一项横断面研究。
Eur J Pediatr. 2024 May;183(5):2383-2389. doi: 10.1007/s00431-024-05496-5. Epub 2024 Mar 7.
7
Predictive value of soluble urokinase-type plasminogen activator receptor for mortality in patients with suspected myocardial infarction.可溶性尿激酶型纤溶酶原激活物受体对疑似心肌梗死患者死亡率的预测价值。
Clin Res Cardiol. 2019 Dec;108(12):1386-1393. doi: 10.1007/s00392-019-01475-1. Epub 2019 Apr 16.
8
The predictive value of soluble urokinase plasminogen activator receptor (SuPAR) regarding 90-day mortality and 12-month neurological outcome in critically ill patients after out-of-hospital cardiac arrest. Data from the prospective FINNRESUSCI study.可溶性尿激酶型纤溶酶原激活物受体(SuPAR)对院外心脏骤停后重症患者90天死亡率和12个月神经功能结局的预测价值。来自前瞻性FINNRESUSCI研究的数据。
Resuscitation. 2014 Nov;85(11):1562-7. doi: 10.1016/j.resuscitation.2014.08.017. Epub 2014 Sep 2.
9
Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality.可溶性尿激酶型纤溶酶原激活物受体在代偿失调性肝硬化中受到区室调节,并提示免疫激活和短期死亡率。
J Intern Med. 2013 Jul;274(1):86-100. doi: 10.1111/joim.12054. Epub 2013 Mar 17.
10
Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Predictor of Incident Atrial Fibrillation.可溶性尿激酶型纤溶酶原激活物受体(suPAR)作为新发心房颤动的预测指标
J Atr Fibrillation. 2018 Apr 30;10(6):1801. doi: 10.4022/jafib.1801. eCollection 2018 Apr.

引用本文的文献

1
Role of Soluble Urokinase-Type Plasminogen Activator Receptor in Cardiovascular Disease.可溶性尿激酶型纤溶酶原激活剂受体在心血管疾病中的作用
Curr Cardiol Rep. 2023 Dec;25(12):1797-1810. doi: 10.1007/s11886-023-01991-7. Epub 2023 Nov 10.
2
Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications.血管外科中的心房颤动:患病率、发病率和结局影响的系统评价和荟萃分析。
J Cardiovasc Med (Hagerstown). 2023 Sep 1;24(9):612-624. doi: 10.2459/JCM.0000000000001533.
3
Postoperative delirium, neuroinflammation, and influencing factors of postoperative delirium: A review.
术后谵妄、神经炎症与术后谵妄的影响因素:综述。
Medicine (Baltimore). 2023 Feb 22;102(8):e32991. doi: 10.1097/MD.0000000000032991.
4
Association of Preoperative Basal Inflammatory State, Measured by Plasma suPAR Levels, with Intraoperative Sublingual Microvascular Perfusion in Patients Undergoing Major Non-Cardiac Surgery.通过血浆可溶性尿激酶型纤溶酶原激活物受体(suPAR)水平测定的术前基础炎症状态与接受非心脏大手术患者术中舌下微血管灌注的相关性
J Clin Med. 2022 Jun 10;11(12):3326. doi: 10.3390/jcm11123326.